Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 1 Hepatitis C Virus Infection Patients

NCT04001608 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C Virus Infection

Interventions

DRUG: Seraprevir
DRUG: Sofosbuvir

Sponsor

Ginkgopharma CO., LTD